Nirman Agri Genetics Ltd
₹ 394
1.99%
13 Dec
- close price
About
Incorporated in 2020, Nirman Agri Genetics Ltd is in the business of manufacturing and processing seeds[1]
Key Points
- Market Cap ₹ 315 Cr.
- Current Price ₹ 394
- High / Low ₹ 484 / 158
- Stock P/E 17.6
- Book Value ₹ 123
- Dividend Yield 0.51 %
- ROCE 33.8 %
- ROE 32.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 35.1%
Cons
- Promoter holding has decreased over last quarter: -8.24%
- Tax rate seems low
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Miscellaneous Industry: Miscellaneous
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2021 8m | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|
| 4 | 13 | 29 | 63 | 152 | |
| 4 | 10 | 24 | 52 | 133 | |
| Operating Profit | 0 | 3 | 4 | 11 | 19 |
| OPM % | 2% | 25% | 15% | 18% | 12% |
| 0 | 0 | 0 | 0 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 3 | 4 | 11 | 18 |
| Tax % | 29% | 25% | 6% | 5% | |
| 0 | 3 | 4 | 10 | 18 | |
| EPS in Rs | 5.01 | 13.00 | 22.42 | ||
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 155% |
| TTM: | 121% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 493% |
| TTM: | 159% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 39% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 35% |
| Last Year: | 32% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 6 | 6 | 8 |
| Reserves | 0 | 3 | 21 | 31 | 90 |
| 1 | 1 | 1 | 1 | 1 | |
| 1 | 2 | 2 | 6 | 4 | |
| Total Liabilities | 2 | 6 | 30 | 44 | 103 |
| 0 | 0 | 1 | 0 | 3 | |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 2 | 6 | 29 | 44 | 101 | |
| Total Assets | 2 | 6 | 30 | 44 | 103 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| -0 | 0 | 0 | 5 | |
| 0 | -0 | -21 | -2 | |
| 1 | 0 | 20 | -1 | |
| Net Cash Flow | 1 | 0 | -1 | 1 |
Ratios
Figures in Rs. Crores
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|
| Debtor Days | 58 | 114 | 52 | 67 |
| Inventory Days | 21 | 25 | 76 | 61 |
| Days Payable | 40 | 38 | 6 | 39 |
| Cash Conversion Cycle | 39 | 101 | 121 | 89 |
| Working Capital Days | 32 | 81 | 91 | 79 |
| ROCE % | 133% | 27% | 34% |
Documents
Announcements
-
Copy of Newspaper Publication
16 November 2024 - Nirman Agri Genetics Limited has informed about Copy of Newspaper Publication
-
Financial Result Updates
14 November 2024 - Nirman Agri Genetics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024.
-
Outcome of Board Meeting
14 November 2024 - Nirman Agri Genetics Limited has informed regarding Board meeting held on November 14, 2024.
-
Capacity addition
12 November 2024 - Nirman Agri Genetics Limited has informed about Capacity addition
-
Board Meeting Intimation
8 November 2024 - NIRMAN AGRI GENETICS LIMITED has informed about Board Meeting to be held on 14-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the …
Business Overview:[1]
a) NAGL is an agricultural input company that produces, processes, and markets premium hybrid seeds, organic fertilizers, and bio-organic seeds for a variety of crops, including corn, sunflower, cotton, rice, sorghum, and grain.
b) It has recently started producing micronutrients and bioproducts.
c) In addition, it grows non-hybrid seeds.
d) Company is working towards creating seeds with greater yield potential, drought resistance, pest and disease tolerance, etc.
e) It is also working on research and development projects about better breeding techniques and biotechnology instruments, which allows it to create hybrid seeds, micronutrients, and bioproducts.